Ohio State University Comprehensive Cancer Center clinical trial pipeline

16 trials changed in the last 30 days: 0 stopped, 10 with notable changes, 6 with minor changes only.

1. Notable

   Virtual Reality Viewing of Unaltered Streetscape Versus Digitally…Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

   Primary and study completion pushed from Dec 31, 2026 to Jan 31, 2028

   Ohio State University Comprehensive Cancer Center·Not applicable· NCT07216534· Registry history of NCT07216534 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation…Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation · Pancreatic Neoplasms

   Primary and study completion pushed from Dec 31, 2027 to Dec 31, 2028

   Also in this update: Enrolling by invitation only; Interventions modified

   Ohio State University Comprehensive Cancer Center·Not applicable· NCT07619417· Registry history of NCT07619417 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

3. Notable

   CLIMB · Confocal Laser Endomicroscopy as an Imaging Biomarker for…CLIMB · Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

   Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2028

   Ohio State University Comprehensive Cancer Center·Not specified· NCT03492151· Registry history of NCT03492151 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

4. Notable

   Ibrutinib and Nivolumab · Relapsed or Refractory Classical Hodgkin…Ibrutinib and Nivolumab · Relapsed or Refractory Classical Hodgkin Lymphoma

   Primary and study completion pushed from Aug 15, 2026 to Feb 15, 2027

   Ohio State University Comprehensive Cancer Center·Phase 2· NCT02940301· Registry history of NCT02940301 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

5. Notable

   Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

   Primary and study completion pushed from Jul 31, 2026 to Jul 31, 2027

   Ohio State University Comprehensive Cancer Center·Not specified· NCT06630429· Registry history of NCT06630429 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

6. Notable

   Imaging and Blood-Based Biomarkers for the Evaluation of Early…Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy

   Primary and study completion pushed from Jun 18, 2026 to Apr 18, 2027

   Ohio State University Comprehensive Cancer Center·Not specified· NCT05717998· Registry history of NCT05717998 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

7. Notable

   DCE-MRI for Neoadjuvant Treatment Assessment · Borderline…DCE-MRI for Neoadjuvant Treatment Assessment · Borderline Resectable Pancreatic Cancer

   Recruitment opened

   Ohio State University Comprehensive Cancer Center·Phase 1/2· NCT07705919· Registry history of NCT07705919 on ClinicalTrials.gov (opens the registry)

   Oct 5, 2026

8. Notable

   Nicotine on Eye Movements and Related Behaviors in Electronic…Nicotine on Eye Movements and Related Behaviors in Electronic Cigarette Users, NICS-EYES Trial

   Recruitment opened

   Ohio State University Comprehensive Cancer Center·Not applicable· NCT07604246· Registry history of NCT07604246 on ClinicalTrials.gov (opens the registry)

   Oct 5, 2026

9. Notable

   Multiomic Analysis in Small-Cell Lung Cancer

   Recruitment opened

   Ohio State University Comprehensive Cancer Center·Not specified· NCT07795411· Registry history of NCT07795411 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

10. Notable

    Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse…Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability

    Recruitment opened

    Ohio State University Comprehensive Cancer Center·Not applicable· NCT07564648· Registry history of NCT07564648 on ClinicalTrials.gov (opens the registry)

    Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.